Krystal Biotech (KRYS) Cash from Investing Activities Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | -170.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.74% |
| Dec 31, 2025 | 60.62% |
| Sep 30, 2025 | 33.75% |
| Jun 30, 2025 | 34.94% |
| Mar 31, 2025 | 0.68% |
| Dec 31, 2024 | 12.84% |
| Sep 30, 2024 | 2.61% |
| Jun 30, 2024 | 32.28% |
| Mar 31, 2024 | -226.42% |
| Dec 31, 2023 | -17.79% |
| Sep 30, 2023 | 244.83% |
| Jun 30, 2023 | -155.03% |
| Mar 31, 2023 | 67.87% |
| Dec 31, 2022 | -106.55% |
| Sep 30, 2022 | -178.57% |
| Jun 30, 2022 | -213.89% |
| Mar 31, 2022 | -182.42% |
| Dec 31, 2021 | -222.66% |
| Sep 30, 2021 | -138.05% |
| Dec 31, 2020 | -239.41% |
| Sep 30, 2020 | -507.99% |
| Jun 30, 2020 | -210.94% |
| Mar 31, 2020 | -471.26% |
| Dec 31, 2019 | -303.44% |